CE
Celanese Corporation · Basic Materials · Chemicals
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | +1 | 464.53K | $20.63M | +1 | n/a |
| Q2 2026 | 124 | -2 | 94.93M | $4.37B | +10 | −11 |
| Q1 2026 | 128 | +4 | 84.09M | $5.53B | +14 | −11 |
| Q4 2025 | 124 | +1 | 95.35M | $4.03B | +2 | n/a |
| Q3 2025 | 22 | -2 | 60.12M | $2.53B | +1 | −4 |
| Q2 2025 | 22 | +2 | 61.12M | $3.38B | +2 | n/a |
| Q1 2025 | 17 | +1 | 40.97M | $2.33B | +2 | −1 |
| Q4 2024 | 16 | +3 | 34.33M | $2.38B | +3 | n/a |
| Q3 2024 | 12 | -5 | 21.87M | $2.97B | n/a | −5 |
| Q2 2024 | 17 | n/a | 24.07M | $3.25B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 431.16K | New | $19.13M | 0.0% | New | 1 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 33.34K | +57.7% | $1.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 30 | 0.0% | $1,325 | 0.0% | Held | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Assenagon Asset Management… | $19.13M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 466 holders, 107.49M shares, $6.95B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer · SVP & CFO · 1.40K sh @ 45.53 · $63,742
Officer · SVP & CFO · 100 sh @ 45.51 · $4,550
Officer · SVP & CFO · 800 sh @ 45.51 · $36,406
Officer · SVP & GC · 600 sh @ 45.60 · $27,360
Officer · SVP - Acetyls · 2.15K sh @ 45.52 · $98,004
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology